Odyssey Health, Inc. (ODYY)
OTCMKTS · Delayed Price · Currency is USD
0.0067
0.00 (0.00%)
At close: Oct 19, 2026
Odyssey Health Employees
Odyssey Health had 2 employees as of July 31, 2025. The number of employees decreased by 2 or 50.00% compared to the previous year. That makes Odyssey Health the 43,498th largest employer in the world and 7,153rd in the United States.
Employees
2
Change (1Y)
-2
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,785,549
Market Cap
738.47K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2025 | 2 | -2 | -50.00% | 2 | 0 |
| Jul 31, 2024 | 4 | -2 | -33.33% | 4 | 0 |
| Jul 31, 2023 | 6 | 2 | 50.00% | 6 | 0 |
| Jul 31, 2022 | 4 | 0 | - | 4 | 0 |
| Jul 31, 2021 | 4 | 1 | 33.33% | 4 | 0 |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Biotricity | 46 |
| Allurion Technologies | 41 |
| Escalon Medical | 39 |
| ENvue Medical | 14 |
| Vycor Medical | 7 |
| Electromedical Technologies | 6 |
| Ludwig Enterprises | 5 |
| IR-Med | 4 |
Odyssey Health News
- 6 months ago - Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth - PRNewsWire
- 11 months ago - Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million - GlobeNewsWire
- 1 year ago - Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace - GlobeNewsWire
- 1 year ago - Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device - GlobeNewsWire
- 2 years ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 2 years ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire